PROK NASDAQ
ProKidney Corp.
1W: -12.9%
1M: -26.2%
3M: -26.5%
YTD: -30.5%
1Y: +92.2%
3Y: -83.0%
$1.55
-0.06 (-3.73%)
Pre-Market: $1.58 (+0.03, +1.94%)
Weekly Expected Move ±5.7%
$1
$2
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$499.5M
52W Range0.54-7.13
Volume876,898
Avg Volume832,000
Beta1.75
Dividend—
Analyst Ratings
Company Info
CEOBruce Culleton
Employees204
SectorHealthcare
IndustryBiotechnology
IPO Date2021-06-30
Websiteprokidney.com
2000 Frontis Plaza Blvd.
Winston-Salem, NC 27103
US
Winston-Salem, NC 27103
US
336 999 7028
About ProKidney Corp.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Latest News
ProKidney GAAP EPS of -$0.14 beats by $0.01, revenue of $0.23M beats by $0.03M
ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights
ProKidney Reports First Quarter 2026 Financial Results and Business Highlights
ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Control Empresarial | C-Conversion | 63,118,645 | — | 2026-04-28 |
| Control Empresarial | C-Conversion | 63,118,645 | — | 2026-04-28 |
| Control Empresarial | C-Conversion | 63,118,645 | — | 2026-04-28 |
| Coulston James | A-Award | 600,000 | $2.24 | 2026-03-01 |
| Weber Darin J. | A-Award | 400,000 | $2.24 | 2026-03-01 |